Biotechnology Jobs

• Maidenhead
• Hybrid · 3 days in office
• US$212,000 – US$251,000 pa
• Director

Leads the full statistical contribution to a clinical development programme, defining statistical strategy for trial design, analysis and regulatory submissions, and representing Biostatistics in interactions with the FDA, EMA and PMDA. Also manages outsourcing to CROs/FSPs and contributes to governance and development-plan decisions across therapeutic areas.

SAS · R

• Opfikon, Switzerland
• Senior

Leads safety review and end-to-end signal detection across a product's lifecycle, using quantitative and qualitative methods alongside Global Safety Leads. Contributes to aggregate safety reports, risk management plans and regulatory responses, and mentors junior PVS staff. Works cross-functionally with Development, Medical Affairs and Regulatory teams on vaccine and national-significance products.

Microsoft Excel

• London
• Hybrid
• £67,900 – £126,100 pa
• Senior

Co-leads cross-functional Clinical Trial Teams and global studies from planning through close-out, managing timelines, budgets, risks and inspection readiness. Partners across global and local functions on recruitment, data operations and vendor performance, while championing operational excellence and continuous improvement.

• Opfikon, Switzerland
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs. Sits on the Therapy Area Leadership Team, co-leads New Product Opportunity reviews, engages external KOLs and investigators, and drives cross-functional due diligence with BD to close deals.

• Maidenhead
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs, as the senior S&E leader within the Therapy Area Leadership Team. Drives proactive sourcing, cross-functional due diligence, and KOL engagement, partnering with BD to advance high-priority opportunities through negotiation and deal close.